Logo-ipp
Submitted: 11 Mar 2022
Accepted: 01 May 2022
ePublished: 28 May 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Immunopathol Persa. 2022;8(2): e31397.
doi: 10.34172/ipp.2022.31397
  Abstract View: 145
  PDF Download: 120

Original

Saccharomyces boulardii plus azithromycin is superior to azithromycin alone in reducing the duration of diarrhea in children with acute colitis: a double-blind randomized placebo-controlled trial

Mitra Ahmadi 1 ORCID logo, Neda Mohtasham 2 ORCID logo, Ahmad Shamsizadeh 3 ORCID logo, Hazhir Javaherizadeh 4* ORCID logo, Bahman Cheraghian 5 ORCID logo, Masumeh Alizadeh 2 ORCID logo

1 Department of Pediatric Gastroenterology, Children’s Medical Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Pediatrics, Children’s Medical Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Department of Pediatric Infectious Disease, Children’s Medical Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4 Alimentary Tract Research Center, Clinical Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 Department of Biostatistics, Faculty of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
*Corresponding Author: *Correspondence to Hazhir Javaherizadeh, Email: Hazhirja@yahoo.com, , Email: Hazhirja@ajums.ac.ir

Abstract

Introduction: Diarrheal disorders remain a major disease burden throughout the world in pediatrics that remains a health problem. Several treatment methods have been proposed to treat diarrhea, however each of them has some problems.

Objectives: The aim of this study was the evaluation the effect of oral Saccharomyces boulardii on the duration and severity of colitis.

Patients and Methods: This randomized clinical trial study included ninety-four patients with acute colitis were enrolled. The children were divided randomly into case and control groups. The control group received supportive treatment including intravenous or oral fluid therapy (ORS solution), antibiotic treatment with azithromycin suspension, and zinc sulfate syrup daily for five days. In addition to the mentioned treatments, the intervention group received S. boulardii as a probiotic capsule. Then, the duration and severity of diarrhea based on the Vesikari score were evaluated for all the patients for five first days.

Results: The mean of Vesikari score after the first day in both groups was similar, while after the third and fifth day in the probiotic group this score was lower than the control group (5.11 ± 1.73 versus 6.13 ± 2.25, P=0.031 and 2.36 ± 1.16 versus 4.28 ±1.19, P<0.001, respectively). Furthermore, the number of diarrhea per day in the probiotic group was significantly lower after the first day in contrast to the control group, which remains significant at the end of the fifth day (2.32 ± 0.51 versus 2.83 ± 1.23, P=0.047). Moreover, we found that the diarrhea duration (P<0.001), fever duration (P=0.029), and duration of hospitalization (P=0.006) were statistically lower in the case group as compared to the control.

Conclusion: Saccharomyces boulardii had a beneficial effect as a probiotic agent in reducing the severity and duration of diarrhea, which could be beneficial for the treatment of colitis.

Trial Registration: The trial protocol was approved by the Iranian Registry of Clinical Trials (identifier: IRCT20161026030525N2); https://www.irct.ir/trial/24229; ethical code: IR.AJUMS.REC.1395.54.


Citation: Ahmadi M, Mohtasham N, Shamsizadeh A, Javaherizadeh H, Cheraghian B, Alizadeh M. Saccharomyces boulardii plus azithromycin is superior to azithromycin alone in reducing the duration of diarrhea in children with acute colitis: a doubleblind randomized placebo-controlled trial. Immunopathol Persa. 2022;8(2):e31397. DOI:10.34172/ ipp.2022.31397.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 146

Your browser does not support the canvas element.


PDF Download: 120

Your browser does not support the canvas element.